{"id":"W4416974763","doi":"10.12809/hkmj2513054","title":"Expert consensus recommendations on the daily clinical use of pembrolizumab for early triple-negative breast cancer","year":2025,"lang":"en","type":"article","venue":"Hong Kong Medical Journal","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Pembrolizumab; Breast cancer; Perioperative; Neoadjuvant therapy; Chemotherapy; Mastectomy; Clinical trial; MEDLINE","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1268306,0.001482133,0.002287626,0.005143406,0.003648122,0.004528834,0.006580614,0.0134299,0.01199778],"category_scores_gemma":[0.163589,0.001363676,0.006067725,0.003726053,0.002556275,0.00495489,0.005855446,0.01076587,0.005149996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009709237,"about_ca_system_score_gemma":0.05628657,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01165471,"about_ca_topic_score_gemma":0.01447962,"domain_scores_codex":[0.9045975,0.05351249,0.02134036,0.002495827,0.01387639,0.004177446],"domain_scores_gemma":[0.7718036,0.06628609,0.01159702,0.003932369,0.1334903,0.0128906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002473813,0.0002787301,0.00198479,0.01606337,0.0002721907,0.0008443572,0.00507104,0.001845144,0.001327736,0.01246034,0.6708227,0.2887822],"study_design_scores_gemma":[0.0004788931,0.000232525,0.003725343,0.05595993,0.0004587852,0.0007274389,0.007160385,0.00122837,0.0008724507,0.02334308,0.9055461,0.0002667201],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"other","genre_scores_codex":[0.0052398,0.04863505,0.02824572,0.8198256,0.02353145,0.01237619,0.003299416,0.0004282099,0.05841861],"genre_scores_gemma":[0.1121561,0.1066365,0.3795315,0.3046208,0.009439144,0.03637629,0.01081224,0.0003731168,0.04005434],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.1268306,"threshold_uncertainty_score":0.6707522,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05384642136366831,"score_gpt":0.3802367739213978,"score_spread":0.3263903525577295,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}